6-16306634-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001128164.2(ATXN1):c.2143G>A(p.Gly715Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000279 in 1,614,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001128164.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATXN1 | NM_001128164.2 | c.2143G>A | p.Gly715Ser | missense_variant | 8/8 | ENST00000436367.6 | NP_001121636.1 | |
ATXN1 | NM_000332.4 | c.2143G>A | p.Gly715Ser | missense_variant | 9/9 | NP_000323.2 | ||
ATXN1 | NM_001357857.2 | c.*1556G>A | 3_prime_UTR_variant | 9/9 | NP_001344786.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATXN1 | ENST00000436367.6 | c.2143G>A | p.Gly715Ser | missense_variant | 8/8 | 1 | NM_001128164.2 | ENSP00000416360 | P1 | |
ATXN1 | ENST00000244769.8 | c.2143G>A | p.Gly715Ser | missense_variant | 9/9 | 1 | ENSP00000244769 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000236 AC: 36AN: 152240Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000278 AC: 70AN: 251424Hom.: 0 AF XY: 0.000324 AC XY: 44AN XY: 135890
GnomAD4 exome AF: 0.000283 AC: 414AN: 1461888Hom.: 0 Cov.: 31 AF XY: 0.000285 AC XY: 207AN XY: 727244
GnomAD4 genome AF: 0.000236 AC: 36AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.000269 AC XY: 20AN XY: 74384
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2016 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at